Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Sundry Debtors

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,517 Cr₹1,559 Cr₹871 Cr₹1,075 Cr₹671 Cr

What is the latest Sundry Debtors ratio of GLAND PHARMA ?

The latest Sundry Debtors ratio of GLAND PHARMA is ₹1,517 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,517 Cr
Mar2024₹1,559 Cr
Mar2023₹871 Cr
Mar2022₹1,075 Cr
Mar2021₹671 Cr

How is Sundry Debtors of GLAND PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,517 Cr
-2.70
Mar2024 ₹1,559 Cr
78.87
Mar2023 ₹871 Cr
-18.93
Mar2022 ₹1,075 Cr
60.19
Mar2021 ₹671 Cr -

Compare Sundry Debtors of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,247.2 Cr -1.1% -7.8% -6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 0.3% 1.6% 12.1% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.1%

-7.8%

-6.6%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses